Literature DB >> 11746988

Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH.

Heidi Van Limbergen1, Bruce Poppe, Lucienne Michaux, Christian Herens, Jill Brown, Luc Noens, Zwi Berneman, Robrecht De Bock, Anne De Paepe, Frank Speleman.   

Abstract

Complex chromosomal aberrations (CCAs) can be detected in a substantial proportion of AML and MDS patients, de novo as well as secondary or therapy-related, and are associated with an adverse prognosis. Comprehensive analysis of the chromosomal rearrangements in these complex karyotypes has been hampered by the limitations of conventional cytogenetics. As a result, our knowledge concerning the cytogenetics of these malignancies is sparse. Here we describe a multiplex-FISH (M-FISH) study of CCAs in 36 patients with AML and MDS. M-FISH generated a genome-wide analysis of chromosomal aberrations in CCAs, establishing several cytogenetic subgroups. -5/5q- was demonstrated in the majority of patients (86%). Other rearrangements (present with or without -5/5q-) included: deletion of 7q (47%), 3q rearrangements (19%), and MLL copy gain or amplification (17%). These genetic subgroups seem to display biological heterogeneity: MLL copy gain or amplification in association with 5q- was detected only in AML patients and was significantly associated with extremely short survival (median overall survival: 30 days, P = 0.0102). A partially cryptic t(4;5)(q31;q31), a balanced t(1;8)(p31;q22), and an unbalanced der(7)t(7;14)(q21;q13) were detected as possible new recurrent rearrangements in association with CCAs. Novel reciprocal translocations included t(5;11)(q33;p15)del(5)(q13q31) and t(3;6)(q26;q25). We conclude that AML and MDS with CCAs can be subdivided into molecular cytogenetic subclasses, which could reflect different clinical behavior and prognosis, and that three recurrent chromosomal aberrations are associated with karyotype complexity. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11746988     DOI: 10.1002/gcc.1212

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  8 in total

Review 1.  Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype.

Authors:  Krzysztof Mrózek
Journal:  Semin Oncol       Date:  2008-08       Impact factor: 4.929

Review 2.  Molecular cytogenetics in haematological malignancy: current technology and future prospects.

Authors:  Lyndal Kearney; Sharon W Horsley
Journal:  Chromosoma       Date:  2005-10-15       Impact factor: 4.316

3.  An analysis of complex chromosomal aberrations in seven cases of myelodysplastic syndromes by M-FISH and whole chromosome painting.

Authors:  Jian-Yong Li; Bing Xiao; Li-Juan Chen; Jin-Lan Pan; Wei Xu; Hai-Rong Qiu; Li Li; Yong-Quan Xue
Journal:  Int J Hematol       Date:  2008-11-11       Impact factor: 2.490

4.  Acute myeloid leukemia with adverse cytogenetic risk.

Authors:  Krzysztof Mrózek; Clara D Bloomfield
Journal:  Oncology (Williston Park)       Date:  2012-08       Impact factor: 2.990

5.  MYC rearrangement involving a novel non-immunoglobulin chromosomal locus in precursor B-cell acute lymphoblastic leukemia.

Authors:  Ja-Young Seo; Soo Hyun Lee; Hee-Jin Kim; Keon Hee Yoo; Hong Hoe Koo; Yong Gon Cho; Sam Im Choi; Sun-Hee Kim
Journal:  Ann Lab Med       Date:  2012-06-20       Impact factor: 3.464

6.  Demonstration of microchimerism in pregnant sows and effects of congenital PRRSV infection.

Authors:  Uladzimir U Karniychuk; Wander Van Breedam; Nadine Van Roy; Claire Rogel-Gaillard; Hans J Nauwynck
Journal:  Vet Res       Date:  2012-03-16       Impact factor: 3.683

7.  Genomic Copy Number Variations in the Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients with del(5q) and/or -7/del(7q).

Authors:  Rui Zhang; Young-Mi Kim; Xianfu Wang; Yan Li; Xianglan Lu; Andrea R Sternenberger; Shibo Li; Ji-Yun Lee
Journal:  Int J Med Sci       Date:  2015-09-01       Impact factor: 3.738

8.  EVI1 activation in blast crisis CML due to juxtaposition to the rare 17q22 partner region as part of a 4-way variant translocation t(9;22).

Authors:  An De Weer; Bruce Poppe; Barbara Cauwelier; Andre Carlier; Jan Dierick; Bruno Verhasselt; Jan Philippé; Nadine Van Roy; Frank Speleman
Journal:  BMC Cancer       Date:  2008-07-09       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.